{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:52:48Z","timestamp":1793195568192,"version":"4.5.0"},"reference-count":32,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Pulmonary hypertension (PH) is a frequently encountered complication of chronic obstructive pulmonary disease (COPD) and is associated with worsened clinical symptoms and prognosis. The prevalence of PH-COPD is not concretely established as classification criteria vary historically, but the presence of severe disease out of proportion to underlying COPD is relatively rare. Right heart catheterization, the gold standard in diagnosis of PH, is infrequently performed in COPD, and the overlap in the clinical symptoms of PH and COPD presents diagnostic challenges. Proven treatments are limited. Trials exploring the use of vasodilator therapy in this patient group generally demonstrate improvements in hemodynamics accompanied by worsening gas exchange without clearly demonstrated improvements in clinically meaningful outcomes. In-depth workup of underlying pulmonary hypertension and use of pulmonary vasodilator medications may be appropriate on an individual basis. We present a case study and a review and discussion of the pertinent literature on this topic.<\/jats:p>","DOI":"10.3390\/medicina55080432","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T11:58:16Z","timestamp":1564747096000},"page":"432","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Pulmonary Hypertension in COPD: A Case Study and Review of the Literature"],"prefix":"10.3390","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8621-9497","authenticated-orcid":false,"given":"Steven J.","family":"Cassady","sequence":"first","affiliation":[{"name":"Department of Pulmonary &amp; Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Reed","sequence":"additional","affiliation":[{"name":"Department of Pulmonary &amp; Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,8,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Simonneau, G., Montani, D., Celermajer, D.S., Denton, C.P., Gatzoulis, M.A., Krowka, M., Williams, P.G., and Souza, R. (2019). Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur. Respir. J., 53.","DOI":"10.1183\/13993003.01913-2018"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"D109","DOI":"10.1016\/j.jacc.2013.10.036","article-title":"Pulmonary hypertension in chronic lung diseases","volume":"62","author":"Seeger","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1183\/09031936.00079512","article-title":"Pulmonary hypertension in COPD: Results from the ASPIRE registry","volume":"41","author":"Hurdman","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/thx.36.10.752","article-title":"Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease","volume":"36","author":"Weitzenblum","year":"1981","journal-title":"Thorax"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.2107027","article-title":"Hemodynamic characterization of patients with severe emphysema","volume":"166","author":"Scharf","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1164\/rccm.200401-006OC","article-title":"Severe pulmonary hypertension and chronic obstructive pulmonary disease","volume":"172","author":"Chaouat","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1086\/674339","article-title":"Pulmonary arterial remodeling in chronic obstructive pulmonary disease is lobe dependent","volume":"3","author":"Wrobel","year":"2013","journal-title":"Pulm. Circ."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1183\/09031936.02.00245902","article-title":"Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD","volume":"19","author":"Santos","year":"2002","journal-title":"Eur. Respir. J."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bunel, V.G.A., Dauriat, G., Danel, C., Montani, D., Gauvain, C., Thabut, G., Humbert, M., Dorfm\u00fcller, P., and Mal, H. (2017). Microvascular changes in COPD patients with severe pulmonary hypertension. Eur. Respir. J., 50.","DOI":"10.1183\/1393003.congress-2017.PA2430"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S2213-2600(17)30291-6","article-title":"Is there a vanishing pulmonary capillary syndrome?","volume":"5","author":"Hoeper","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1700354","DOI":"10.1183\/13993003.00354-2017","article-title":"More on idiopathic pulmonary arterial hypertension with a low diffusing capacity","volume":"50","author":"Olsson","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0954-6111(03)00129-X","article-title":"Endothelin-1 levels in the pathophysiology of chronic obstructive pulmonary disease and bronchial asthma","volume":"97","author":"Spiropoulos","year":"2003","journal-title":"Respir. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension","volume":"333","author":"Giaid","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1164\/rccm.200605-724OC","article-title":"Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke","volume":"175","author":"Lee","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1183\/13993003.02030-2015","article-title":"Microarray analysis in pulmonary hypertension","volume":"48","author":"Hoffmann","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1164\/ajrccm.164.2.2006129","article-title":"\u201cNatural history\u201d of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease","volume":"164","author":"Kessler","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.echo.2013.02.002","article-title":"Estimation of pulmonary pressures and diagnosis of pulmonary hypertension by Doppler echocardiography: A retrospective comparison of routine echocardiography and invasive hemodynamics","volume":"26","author":"Lafitte","year":"2013","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10554-017-1069-3","article-title":"Investigating the value of right heart echocardiographic metrics for detection of pulmonary hypertension in patients with advanced lung disease","volume":"33","author":"Amsallem","year":"2017","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1164\/rccm.200210-1130OC","article-title":"Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease","volume":"167","author":"Arcasoy","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1378\/chest.13-1422","article-title":"CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD","volume":"145","author":"Iyer","year":"2014","journal-title":"Chest"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7326\/0003-4819-102-1-29","article-title":"Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease","volume":"102","author":"Timms","year":"1985","journal-title":"Ann. Intern. Med."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Long-Term Oxygen Treatment Trial Research (2016). A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N. Engl. J. Med., 375, 1617\u20131627.","DOI":"10.1056\/NEJMoa1604344"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.healun.2016.04.010","article-title":"Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial","volume":"36","author":"Vitulo","year":"2017","journal-title":"J. Heart Lung Transplant"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S2213-2600(14)70013-X","article-title":"Tadalafil in patients with chronic obstructive pulmonary disease: A randomised, double-blind, parallel-group, placebo-controlled trial","volume":"2","author":"Goudie","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1183\/09031936.00011308","article-title":"A randomised, controlled trial of bosentan in severe COPD","volume":"32","author":"Stolz","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1753465808103499","article-title":"Effect of bosentan upon pulmonary hypertension in chronic obstructive pulmonary disease","volume":"3","author":"Valerio","year":"2009","journal-title":"Ther. Adv. Respir. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.2147\/COPD.S141798","article-title":"Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension","volume":"12","author":"Wang","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1086\/689291","article-title":"The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease","volume":"7","author":"Bajwa","year":"2017","journal-title":"Pulm. Circ."},{"key":"ref_30","first-page":"OA5000","article-title":"Pulmonary hypertension due to lung disease\u2014Results from COMPERA","volume":"46","author":"Grunig","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.rmed.2019.03.004","article-title":"Outcomes of lung disease-associated pulmonary hypertension and impact of elevated pulmonary vascular resistance","volume":"150","author":"Awerbach","year":"2019","journal-title":"Respir. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1203830","article-title":"Pulmonary arterial enlargement and acute exacerbations of COPD","volume":"367","author":"Wells","year":"2012","journal-title":"N. Engl. J. Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/55\/8\/432\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:12:48Z","timestamp":1760188368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/55\/8\/432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["medicina55080432"],"URL":"https:\/\/doi.org\/10.3390\/medicina55080432","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,2]]}}}